Marinus Pharmaceuticals, Inc.

Q2 2021 13F Holders

Symbol
MRNS
CUSIP
56854Q200
Type
Equity
Class
COM NEW
Num filings
91
Total reported value, excl. options
$563 M
Manager Report Date Value ($000) Shares Option Type